U.S., March 27 -- ClinicalTrials.gov registry received information related to the study (NCT06895941) titled 'Predictive Value of PET/CT for Efficacy of Neoadjuvant Immunotherapy in Non-small Cell Lung Cancer' on March 20.
Brief Summary: The aim of this study was to investigate the enhancement of FAPI PET/CT metabolic parameters in predicting the efficacy performance of neoadjuvant immunotherapy using the pCR status of surgically resected specimens of lung cancer as the gold standard.
Study Start Date: March 24
Study Type: OBSERVATIONAL
Condition:
Lung Cancer (NSCLC)
Neoadjuvant Immunotherapy
Intervention:
DIAGNOSTIC_TEST: PET
Exploring the predictive value of PET/CT metabolic parameters for the efficacy of neoadjuvant immunotherapy...